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RespirationThe sequential ﬂow of electrons in the respiratory chain, from a low reduction potential substrate to O2, is
mediated by protein-bound redox cofactors. In mitochondria, hemes—together with ﬂavin, iron–sulfur, and
copper cofactors—mediate this multi-electron transfer. Hemes, in three different forms, are used as a
protein-bound prosthetic group in succinate dehydrogenase (complex II), in bc1 complex (complex III) and
in cytochrome c oxidase (complex IV). The exact function of heme b in complex II is still unclear, and lags be-
hind in operational detail that is available for the hemes of complex III and IV. The two b hemes of complex III
participate in the unique bifurcation of electron ﬂow from the oxidation of ubiquinol, while heme c of the cy-
tochrome c subunit, Cyt1, transfers these electrons to the peripheral cytochrome c. The unique heme a3, with
CuB, form a catalytic site in complex IV that binds and reduces molecular oxygen. In addition to providing cat-
alytic and electron transfer operations, hemes also serve a critical role in the assembly of these respiratory
complexes, which is just beginning to be understood. In the absence of heme, the assembly of complex II is
impaired, especially in mammalian cells. In complex III, a covalent attachment of the heme to apo-Cyt1 is a
prerequisite for the complete assembly of bc1, whereas in complex IV, heme a is required for the proper fold-
ing of the Cox 1 subunit and subsequent assembly. In this review, we provide further details of the aforemen-
tioned processes with respect to the hemes of the mitochondrial respiratory complexes. This article is part of
a Special Issue entitled: Cell Biology of Metals
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Insertion of a ferrous iron atom into the porphyrin macrocycle by
the enzyme ferrochelatase creates heme, which is a common cofactor
used for a multitude of biological reactions. Within a protein scaffold,
heme can carry out O2 transport [1], nitric oxide and carbon monoxide
sensing [2], oxygenase reactions [3], enzyme activity regulation [4,5],
and electron transport [6]. The latter function is central in the mecha-
nism associated with the driving force in oxidative phosphorylation.
In eukaryotic cells, seven hemes of differing architecture (hemes b, c
and a) are embedded in the proteins of the electron transport chain
(ETC), and they are reduced and oxidized in generally increasing reduc-
tion potentials to transfer four electrons ultimately to reduceO2 (Fig. 1).
These “cellular pigments,” or cytochromes, give rise to spectral absorp-
tion bands from heme b of complex II (succinate dehydrogenase),
hemes b of complex III (bc1 complex), hemes a of complex IV (cyto-
chrome c oxidase) and hemes c of complex III and the soluble electroniology of Metals.
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nge).
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l rights reserved.mediator, cytochrome c. Complex I (NADH Dehydrogenase) contains
ﬂavin and iron–sulfur cofactors, but is devoid of hemes.
For efﬁcient long-range electron transfer, and to generate a proton
gradient across the inner membrane of mitochondria or plasma mem-
brane of bacteria, nature has evolved highly specialized modiﬁcations to
heme to ﬁne tune the electron relay system. For instance, heme a is pre-
sent only in terminal oxidases. It is synthesized fromheme b (protoheme)
—the product of ferrochelatase—by two sequential chemical modiﬁca-
tions using two specialized enzymes: heme o synthase (HOS) and heme
a synthase (HAS). HOS converts one of the vinyl carbon of themacrocycle
into a hydrophobic hydroxyfarnesyl tail (heme o) followed by a HAS cat-
alyzed conversion of one of the methyl carbon of the macrocycle to a
formyl group (heme a). The latter methyl group oxidation results in a
marked increase in the mid-point potential (~+180mV) of heme a
relative to heme o [7,8]. The farnesyl tail serves a structural role in
stabilizing, via hydrophobic interactions, the helical structure of the
Cox1 subunit of cytochrome c oxidase (CcO) [9]. These two heme a
prosthetic groups are necessary for electron transfer and O2 reduction
activities in CcO.
Protein scaffolds are also used to provide a modiﬁcation to the
heme macrocycle. Proteins bind hemes via the combination of three
interactions: (i) the interaction between an axial ligand and the
heme iron; (ii) hydrophobic interactions between the protein and
the porphyrin macrocycle; and (iii) polar interactions between the
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this heme-protein interaction, heme b can be covalently attached to
the protein backbone, which deﬁnes the heme as c-type. Proteins
with c-type hemes (cytochromes c) contain a CxxCH heme-binding
motif where two cysteine (rarely one cysteine) residues form
thioether linkages to the vinyl carbons of the heme macrocycle, and
the His residue binds to the axial position of the heme iron.
The above specialization is not necessarily to provide tuning of the
redox potential of the heme as previously believed; the potential can
more easily be tuned over a wide range using only the protein envi-
ronment [10,11]. The c-type modiﬁcation does add structural stability
of the heme-protein complex over its cytochrome b globin counter-
part [12]. In addition to being a cofactor in the soluble cytochrome c
found in the inter-membrane space (IMS) of mitochondria, covalently
bound heme is also a cofactor in the cytochrome c1 subunit of the bc1
complex. It is interesting to note that both the non-covalently linked
b and a hemes of the respiratory chain reside in the relatively protec-
ted environments within the inner membrane (IM) and the matrix,
whereas both c hemes of cytochrome c1 and cytochrome c reside in
the more oxidizing intermembrane space, analogous to the harsher
environment of the periplasm in bacteria where a stable heme link-
age might be advantageous.
In this review, we take a hemocentric view of the mitochondrial
respiratory chain. We describe the heme cofactors from structural
and functional perspectives, and also the assembly of heme cofactor
centers within respiratory complexes II, III, and IV. We focus on the
respiratory complexes from the yeast Saccharomyces cerevisiae with
information from bacterial and mammalian systems when appropri-
ate for comparisons and when yeast information is lacking.
2. The heme moiety of succinate dehydrogenase (SDH)
2.1. Overview
Succinate dehydrogenase (SDH, complex II), also known as succi-
nate:quinone oxidoreductase in bacterial systems (SQR), is a hetero-b
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Fig. 1. Distribution of hemes b, c, and a, with respective midpoint potentials, in respiratory c
potential from the b heme of Complex II to the a3 heme of Complex IV, the site of the termin
clarity: Complex II; FAD, [2Fe–2S], [4Fe–4S], [3Fe–4S]: Complex III; Rieske 2Fe–2S: Complex I
of the subunit. References used for midpoint potentials: Complex II [21]; Complex III [124];
and 2OCC.tetrameric, integral membrane–protein complex (~120 kDa) that
catalyzes the FAD-dependent, two-electron oxidation of succinate to
fumarate, coupled with the reduction of ubiquinone to ubiquinol
[13–16]. It is one of the eight enzymes of the citric acid cycle. It is
also part of the aerobic respiratory chain, as it transfers reducing
equivalents to the bc1 complex in the form of quinol. SDH is the
only enzyme that couples the Kreb's cycle to the respiratory electron
transport chain, although unlike the other respiratory complexes,
there is no proton transfer across the membrane coupled with its ac-
tivity. The closely related menaquinol:fumarate oxidoreductase
(QFR) catalyzes the reverse reaction in bacteria during anaerobic res-
piration, and due to the structural and sequence similarities between
SQR and QFR, both enzymes are believed to have evolved from a com-
mon ancestor [15,17].
The two electrons abstracted from the dehydrogenation of succi-
nate are channeled sequentially into the ETC, from the ﬂavin adenine
dinucleotide (FAD) to the membrane-entrapped ubiquinone (UQ),
through the cofactors [2Fe–2S], [4Fe–4S], [3Fe–4S] and possibly
heme b. This long-range, near-linear electron conduit extends over
40 Å from the soluble catalytic domain of SDH to the membrane-
anchoring domain of the enzyme [18]. The participation of heme b
as part of the electron transfer chain has not been clearly established,
so the functional signiﬁcance of heme within SDH is unclear (see
Section 2.4).
Although a few exceptions exist, SDH is in general comprised of
four distinct polypeptides designated Sdh1–4 in yeast (SDHA-D in
bacteria and humans). Sdh1 is a large ~70-kDa ﬂavoprotein (Fp)
with a mono/dinucleotide-binding Rossmann fold [19] that contains
a buried, covalently attached FAD via a histidine residue. The three
distinct iron–sulfur clusters in the ~27-kDa Sdh2 act as an electron
wire connecting the FAD to the ubiquinone-binding site. The Sdh1–
Sdh2 catalytic dimer is oriented exclusively on the matrix side of
the IM in eukaryotes and cytosolic side of the plasma membrane in
bacteria. Two hydrophobic membrane-spanning subunits (Sdh3 and
Sdh4) anchor the catalytic dimer to the membrane and, due to their
relevance to heme, are discussed in detail below.220 mV365 mV
aa3
c
V
V
+235 mV
Cytochrome c Oxidase
IV
Cytochrome c
ytochrome c
ductase
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omplexes II, III, and IV in the mitochondria. Note the general trend of increasing redox
al electron acceptor and O2 reduction. Other cofactors in the complexes are grayed for
V; binuclear CuA, CuB. Complex III is shown as a dimer with cytochrome c docked to one
Complex IV [125]. The ﬁgure was generated using PDB accession numbers: 1YQ3, 3CX5
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The small membrane-spanning domains, Sdh3 (SdhC, ~15 kDa)
and Sdh4 (SdhD, ~14 kDa), together form a classical six-helix bundle.
SDH crystal structures from Escherichia coli, porcine, and avian have
conﬁrmed the presence of a six-coordinate bis-His heme b located
at the inter-subunit interface to form what is referred to as a cyto-
chrome b domain. Heme propionate groups interact with nearby
charged Arg and His residues [18,20] with further stabilization by hy-
drophobic interactions between the porphyrin group and four of the
six helices [20]. The heme lies spatially close to the UQ-binding cavity
located near the matrix-lipid interface comprised of Sdh2, Sdh3 and
Sdh4 [18] and proximal to the [3Fe–4S] center (UQp). A second UQ
site, distal to the 3Fe–4S cluster (Uqd), has been suspected in mito-
chondrial SDH [21]. The crystal structure of porcine SDH provided fur-
ther evidence of this second site based on the presence of a Q site
inhibitor, and that this second site is located close to the IMS side of
the IM [20]. This structure places the heme in between the two UQ-
binding sites and poses interesting speculative scenarios regarding
the electron ﬂux in the transmembrane (TM) domain. For instance,
the two electrons from the oxidation of succinate could ﬂow sequen-
tially to the Qp site, and when ubiquinone reduction becomes rate
limiting for electron ﬂux, the excess electrons could then be trans-
ferred to the Qd site mediated by heme b. This heme pathwaymay as-
sist in the coordination of succinate and UQ turnover rates.
The superfamily of SQR, and the related QFR proteins, can be clas-
siﬁed into ﬁve subfamilies (type A to E) based on variations in the
membrane-anchoring subunits [15,21]. A single group associated
with Archaea (Type E) lacks the typical Sdh3–Sdh4 association to
the membrane and likely lacks heme. QFR enzymes from the Type D
group also lack heme, although they contain the two distinct hydro-
phobic domains in which heme would reside. However, all SQR pro-
teins that contain the distinct membrane anchors contain one to
two hemes b [15]. Thus, the presence of the heme between the two
TM domains is highly conserved, suggesting functional importance.
Curiously, though, investigations into functionally characterizing
this heme have brought into question the physiological importance
of this redox center and whether the heme is required for assembly
of SDH [22–24].
2.3. The Physical and Thermodynamic Barriers to Electron Transfer to
Heme b
The chain of FAD-[2Fe–2S]-[4Fe–4S]-[3Fe–4S]-UQ are all posi-
tioned within a relatively short edge-to-edge distance (10–14 Å) be-
tween each pair of cofactors that allows electrons to tunnel rapidly
between them [25]. Heme b lies curiously outside this linear chain;
the UQ is positioned between the [3Fe–4S] cluster and the heme,
resulting in what appears to be a branching of the electronic path at
the [3Fe–4S] cluster (Fig. 2). Furthermore, the edge to edge distance
between the [3Fe–4S] cluster and heme b (11.4 Å) is greater than
the distance to UQ (7.6 Å) [18,20]. Although this spatial position of
heme b does not necessarily indicate directional speciﬁcity, the no-
tion that the heme is not involved is further substantiated by the
redox potentials of the three cofactors in question. The potential of
heme b (−185 mV), is considerably lower than that of the [3Fe–4S]
cluster (+60 mV) and of ubiquinone reduction (+113 mV) that
would indicate an uphill electron transfer [21]. Thus, both in structur-
al and thermodynamic terms, a sound, albeit theoretical, argument
can be made that the heme may not be part of the electronic pathway
from FAD to UQ.
A caveat to the above argument is the presumption that each
redox center is discrete and operates independently of neighboring
redox centers. However, with close edge to edge distances, deviations
from Nernstian behavior might be likely and that allosteric electronic
interactions between the redox centers could exist [26,27]. Thus,under physiological conditions, the reduction of one redox center
could inﬂuence the potential of the neighboring center to a more fa-
vorable value for reduction. Additionally, and as mentioned in the
previous section, the presence of a second distal UQ binding site
places the heme between the two UQ-binding sites. This raises the
possibility that the heme could function to deliver electrons to the
second Qd site.
2.4. The functional role of heme in SDH
Much of the investigations into the function of the heme in SDH
have utilized E. coli SQR as a model system due to its high protein
expression levels and easy genetic manipulations. Comparison of
the crystal structures of E. coli [18] and mitochondrial SQRs [20]
showed that the heme-binding His residues are conserved, lending
validation to use of the E. coli model system. An exception to this
conservation is found in S. cerevisiae, where one of the His ligands
is replaced by a Tyr, which has led to an interesting debate regarding
the presence of the heme in yeast.
The literature regarding the functional aspect of the heme in SDH
spans three decades. While true that the heme is not involved in ca-
talysis of succinate or fumarate, the exact nature of its function in
electron transfer is still unclear. Heme might have a structural role
in stabilizing the two TM subunits; however, the QFR from E. coli
lacks heme with no effect on its stability [28]. Some SQRs and QFRs
contain two hemes of high and low potentials, reminiscent of the
bc1 complex hemes bH and bL hemes involved in trans-membrane
electron transfer (see Section 3). Heme could be involved in the pre-
vention of reactive oxygen species (ROS) formation during electron
transfer from FAD to UQ by acting as a capacitor in times of high elec-
tron ﬂux [18]. The presence of the heme center may prevent ROS for-
mation with reverse electron ﬂow from ubiquinol, minimizing the
level of semiquinone.
It is clear that SDH contains a bound heme moiety; thus, the major
question relates to the function of the heme center. Below, we high-
light some studies focused on the functional aspects of the heme in
SDH from bacteria, yeast, and mammals.
2.4.1. Effect of heme on the assembly and activity of SDH in bacteria
Initial hints of coupling between heme and the assembly of SDHwas
described using heme-deﬁcient Bacillus subtilis strains where abroga-
tion of heme synthesis resulted in a decrease in membrane-bound
SDH [29]. Parallel to this decrease, Sdh1 (presumed to be associated
with Sdh2) was found in the cytosolic fraction in an increased amount.
This led to the conclusion that the cytochrome b subunits cannot anchor
the Sdh1–Sdh2 complex in the absence of heme.
Corroborating these early observations, E. coli cells that lack the
gene for either of the two TM subunits form only the catalytic
Sdh1–Sdh2 heterodimer and its succinate oxidase activity is found
only in the cytoplasmic fraction [30,31]. Expression of all four sub-
units in a heme-deﬁcient, ferrochelatase mutant results in the same
phenotype where the catalytic SQR was found only in the cytoplasmic
fraction, suggesting heme is required for the proper insertion of SQR
into the membranes. The two TM subunits could not be found in
the membranes when heme was not present [31]. When heme is
presented to cells lacking ferrochelatase, SQR is assembled and active
within the membrane.
Subsequent studies, conducted to analyze the role of heme in SDH,
have employed the generation of site-directed mutants of the heme-
binding ligands [22–24,32,33]. Anaerobic expression of SQR E. coli
histidyl mutants, SDHC H84L or SDHD H71Q, from a plasmid showed
that heme was retained in an altered six-coordinated environment, or
as a penta-coordinated high-spin heme, respectively, as determined
by EPR [33]. The enzyme was shown to be catalytically active, but
with lowered activities and lowered substrate afﬁnity. Contrary to
these results, the same mutants when expressed aerobically showed
Fig. 2. Structural and thermodynamic barriers to electron transfer from the 3Fe–4S cluster
to heme b during quinone reduction in complex II. The transfer of an electron from the
3Fe–4S cluster (yellow and red spheres) to a lower potential heme b (yellow stick)
would involve an “uphill” transfer, whereas a transfer to the higher potential quinone
(green stick)would bemore favorable thermodynamically. Furthermore, electron transfer
to heme b involves a longer distance relative to the distance to the quinone. Subunit 2; yel-
low: Subunit 3; purple: Subunit 4; green. PDB accession number: 1YQ3 was used to gen-
erate the ﬁgure.
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catalytically active [32].
Substitution of the same histidyl ligands to tyrosine residues
(SDHC H84Y or SDHD H71Y), either as a single or double mutant, ap-
pears to cause a loss of the heme in SDH in E. coli cells grown under a
microaerobic condition. The most convincing case was demonstrated
using enriched, overexpressed SQRmutants in E. coliwhere the loss of
the cofactor was conﬁrmed via optical and EPR spectra of the solubi-
lized membranes [23,24]. Cells harboring either of these mutations
grew in succinate-supplemented medium with a doubling time simi-
lar to WT cells. According to the authors, the loss of the heme did not
cause an assembly defect, based partly on the fact that all four sub-
units were visible by SDS-PAGE analysis. The mutant enzyme was
compromised in catalytic activity and substrate afﬁnity as measured
by quinone reduction. The substitution of the His ligand with a Cys
residue induces a penta-coordinated high-spin heme that can bind
CO, indicating that the Cys residue is unable to provide the sixth co-
ordination site to heme b [24]. This result has implications to the
yeast SDH, which is believed by some to bind heme using a Cys res-
idue [34].2.4.2. Effect of heme on the assembly and activity of SDH in eukaryotes
A phylogenetic analysis of SDH from S. cerevisiae places the en-
zyme in the type C subgroup of SQR/FRD superfamily of proteins
based on the sequence of either of the catalytic subunits [15]. All
type C enzymes possess two transmembrane subunits with a single
inter-subunit heme b. Thus, the prediction based on this in silico anal-
ysis is that SDH in yeast is a single heme-containing enzyme. Howev-
er, it has been suggested that yeast SDH may lack heme altogether,
perhaps giving way to evolutionary pressure to dispense the heme
from a possible lack of need [24].
Before any SQR/FRD structural information was available, biochem-
ical evidence indicated the presence of a SDH-speciﬁc heme in a ratio of
~1 mol of hemepermol of FAD in yeastmembranes [34]. The hemewas
termed “fumarate-oxidizable heme” and corresponds to an absorbance
peak at 562 nm that appears in a difference spectrum after the addition
of fumarate to dithionite-reduced mitochondrial membranes. The
562 nm heme peak is not present in mutants lacking either Sdh3 orSdh4. The reliability of using the fumarate-oxidizable spectrumas an in-
dicator of a SDH-associated hemehas beenquestioned; however, due to
contributions from the more abundant cytochromes b from complex III
having an absorption at 563–564 nm [24]. The absence of the heme
562 nm peak in a Sdh3 or Sdh4 deletion; however, appears to be sug-
gestive of a non-complex III dependent peak.
Mutation of either of the identiﬁed residues to alanines (Sdh3
H106A or Sdh4 C78A) causes a decrease in 562 nm heme content
in mitochondrial membranes as measured by fumarate-oxidizable
difference absorbance spectra [34]. It also led to a shift in the λ
max from 562 to 560 nm. Both results suggest partial loss of the
heme; the remaining heme existed in an altered environment. The
steady-state level of assembled SDH and thus total SDH activity
was reduced in both mutants. The stability of the SDH complex
may be decreased from the loss of the heme. These results mirror
those seen with the E. coli system: the amount of assembled enzyme
decreases by about half, with parallel decreases in speciﬁc activity. A
subsequent follow-up yeast study showed that mutation of both
Sdh3 H106A and Sdh4 C78A results in a complete absence of the cy-
tochrome b 562 nm peak in the fumarate-oxidizable absorption
spectrum of the mitochondrial membranes [22]. Covalent FAD levels
decreased ~30% and catalytic activity of the membranes decreased
~53%.
In mammalian cells, mutations harboring SDHC H127A and SDHC
H127Y were constructed in Sdh3 to mimic the mutations mentioned
above made in yeast and in E. coli, respectively [35]. However, unlike
the effects in yeast and in E. coli, a change in the heme-binding ligand
in SDHC led to the conclusion that heme is indispensable for SDH as-
sembly in mammalian cells. For both SDHC H127A and SDHC H127Y
transient reconstitutions in HeLa cells with downregulated endoge-
nous SDHC, steady-state levels of SDHC were signiﬁcantly decreased.
Concomitant decreases in enzyme activities of about 50% were also
observed [35]. Stable reconstitution of the same SDHC mutants in
SDHC negative cells caused an even more dramatic effect with a
near complete loss of SDHC and SDHD steady-state protein levels
and near complete loss of SDH activities. These results would suggest
that either SDH assembly was completely impaired, or that the as-
sembled complex is rapidly degraded resulting from destabilization
in the absence of the heme.2.5. Dual function of Sdh3
The heme in yeast SDH (or its absence) has become even more in-
triguing recently—the Sdh3–Sdh4 heme-containing domain has been
identiﬁed in another, separate mitochondrial protein complex. In S.
cerevisiae, the Sdh3 subunit forms a heterodimer with Tim18 as part
of the TIM22 channel-forming, protein translocase complex [36].
This translocase functions to import nuclear-encoded carrier family
proteins destined to the mitochondria [37,38]. Sdh3 and Tim18 likely
form a membrane anchor complex very similar to the Sdh3/Sdh4
membrane anchor in SDH. Using structural prediction based on pig
and chicken complex II structures as templates, the overall fold of
Tim18 shares an identical three-transmembrane helical bundle
fold to that of Sdh4, and the predicted Sdh4–Tim18 structures can
be superimposed with relatively small deviations. Remarkably, the
quinone-binding site of Sdh3–Sdh4 is conserved in Sdh3–Tim18,
both in terms of structure and the residues involved in forming
the quinone ligands [24,36]. The atypical tyrosine residue in yeast
Sdh4 that replaces the conserved heme-binding His residue is also
present in Tim18, suggesting that this Tyr residue could be critical
for function both in Sdh4 and in Tim18. One major unanswered
question is whether the Sdh3–Tim18 complex contains a heme at
the interface of the heterodimer utilizing this Tyr residue, and if
so, whether this heme is merely a structural moiety or has an addi-
tional functional role.
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Fig. 3. Arrangement of the hemes and the Rieske iron–sulfur clusters in the bc1 dimeric
complex. For clarity, the protein backbone is in transparent grey and only the cofactors
corresponding to a monomeric unit are labeled. The axial ligands to the heme iron are
highlighted along with respective residue numbers and subunits (PDB ID: 3CX5 num-
bering). The axial ligands to heme bL are His183 and His82 (not shown) of Cob. The
quinone analogue inhibitor stigmatellin (Stg) is also shown and denotes the p-side
quinone-binding site that is located between the low potential b heme (Heme bL)
and the Rieske iron–sulfur cluster. The n-side quinone-binding site (not shown) lies
close to the high potential b heme (Heme bH).
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3.1. Overview
The ubiquinol:cytochrome c oxidoreductase (cytochrome bc1,
complex III) is a central component of the respiratory and photosyn-
thetic electron transport chains involved in oxidative phosphoryla-
tion. In eukaryotes, the complex exists as a dimer, embedded in the
IM of mitochondria. In many bacteria, bc1 complexes are present in
the plasma membrane, and the bc1 complex equivalent, the b6f com-
plex, is located in the thylakoid membrane of cyanobacteria and
plant chloroplasts. The function of the bc1 complex is to mediate
transfer of electrons to the diffusible soluble cytochrome c via the
oxidation of membrane-localized quinol, which can be generated
by SDH, as described above. This redox-dependent reaction is
coupled to translocation of protons across the lipid bilayer in
which the complex resides.
All bc1 complexes contain three protein subunits with redox pros-
thetic groups known as the core subunits: a di-heme cytochrome b
(Cob) containing both the high-potential bH (b562) and the lower-
potential bL (b565); the c-type heme c1 associated with the Cyt1 sub-
unit; and an iron–sulfur protein (ISP, Rip1) with a Rieske-type 2Fe–2S
cluster (Fig. 3). Bacterial bc1 complexes usually contain only these
core subunits, and at most, a single supernumerary (containing no
redox cofactors) subunit, whereas the mitochondrial enzymes con-
tain up to eight supernumerary subunits per monomer. The supernu-
merary subunits are not required for either electron ﬂow or proton
translocation by the bc1 complexes. In accordance with the endosym-
biotic theory of mitochondrial origin, the catalytic core of each bc1
monomer in eukaryotes is comprised of the same essential redox
cofactor-containing subunits with a high degree of conservation be-
tween kingdoms.
The redox protein Cob is the only bc1 subunit encoded by the yeast
mitochondrial genome. It contains eight TM helices containing two
heme bmoieties and serves as the foundational protein in bc1 biogen-
esis. The other subunits are encoded by the nuclear genome and must
be imported into the mitochondria. Both the Cyt1 and ISP catalytic
subunits are anchored in the IM by a single TM domain and contain
a soluble globular domain containing its heme c1 and 2Fe–2S and
prosthetic groups, respectively, in the IMS. The ISP protein is inter-
twined between adjacent monomers of the complex, with its globular
domain in one unit and its TM helix in the adjacent unit. Thus, elec-
tron transfer can only occur when the complex is assembled as a
dimer. Furthermore, movement of the globular catalytic domain in
ISP is essential to the electron transfer to cytochrome c1 in the catalyt-
ic mechanism. The dimeric bc1 complex forms higher-order super-
complexes with CcO (Section 4) in yeast and with both CcO and the
NADH dehydrogenase (complex I) in higher eukaryotes.
3.2. Organization and function of bc1 complex redox sites
3.2.1. Structure of bc1 complex heme sites
High-resolution crystal structures of the bovine, chicken and yeast
bc1 complexes identify the redox-active sites within the enzyme
[39–42]. Each bc1 monomer has three 6-coordinate, low-spin heme
centers. The midpoint reduction potentials for heme bH, heme bL,
and heme c1 are~+120 mV, ~−30 mV, and ~+240 mV, respectively
[43], although there is slight variation between species and strains
(Figs. 1 and 3).
The di-heme cytochrome b polypeptide forms the two quinone-
binding sites. According to the crystal structures, the two planar b-
type hemes are rotated approximately 45o to one another, but are
positioned perpendicular to the IM within a four-helix bundle of
the cytochrome b subunit. Earlier spectroscopic and mutagenesis
[44] studies determined that two His residues in each of the second
(helix B) and fourth (helix D) TM helices bind the hemes. TheseHis residues are invariant in over 800 sequences of b-type cyto-
chromes, including cytochrome b6 of the b6f complex [45]. The dis-
tance between the heme iron atoms and the ligating His varies
from 2.05 to 2.08 Å [39–42]. The distance between the iron centers
of the b hemes in the same monomer is approximately 21 Å
[40–42]. Interestingly, this same distance is also observed for the bL
hemes in opposite monomers, implying that electron transfer may
be possible between them [46]. The low-potential heme bL is located
close to the IMS side of the IM, but protected from solvent by the cy-
tochrome c1 subunit. Conversely, the high-potential heme bH is locat-
ed near the surface of Cob in a solvent-ﬁlled cavity accessible from
the matrix. In this location, heme bH can receive electrons from bL
to drive the Q cycle.
The IMS-localized domain of the cytochrome c1 subunit (Cyt1)
contains a single heme c1 moiety that is covalently attached to the
polypeptide by two thioether bonds to Cyt1 cysteine residues [40]
(a rare one thioether bond Cyt1 exists [47]). Cyt1 is larger and differs
in structural elements from other c-type cytochromes in addition to
having a TM segment [48]. Like most apo-cytochromes c, a CxxCH
motif provides the sulfhydryls for the two thioether bonds and the
imidazole nitrogen of histidine serves as the ﬁfth axial ligand to the
heme iron. Methionine is typically the sixth axial iron ligand.
3.2.2. Catalytic mechanism of the bc1 complex
Details of the bc1 catalytic mechanism can be found in many excel-
lent reviews [49–51]. Here, we provide a general overview while
highlighting hemes' roles. A central function of the two hemes, bH
and bL, is to provide a bifurcation pathway to the two electrons ab-
stracted from the oxidation of quinol. The third heme of bc1, heme
c1, accepts electrons from the Rieske 2Fe–2S cluster and mediates
them to the soluble cytochrome c. Speciﬁcs are outlined below.
The bc1 complex contains two quinone reaction centers located on
opposite sides within the IM [52] (Fig. 3). Ubiquinol binds at the Qo, or
the P site of the complex. After deprotonation, one electron is released
to reduce sequentially the Rieske 2Fe–2S cluster, heme c1 and then
heme c of the soluble cytochrome c. The second electron is passed
to the low-potential heme bL and then to the high-potential heme
bH which is then used to reduce the quinone at the Qi, or N site, for-
ming a semiquinone. Another cycle of quinol oxidation at the Qo site
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semiquinone at the Qi site from the ﬁrst reaction sequence. The
resulting quinol re-enters the Q cycle at the Qo site. Thus, the net
product of the Q cycle is the translocation of four protons to the
IMS, the uptake of two protons from the mitochondrial matrix, and
the reduction of two molecules of cytochrome c.
While the overall reaction mechanism remains largely undisputed,
the bifurcated oxidation of ubiquinol is proposed to occur by two differ-
ent mechanisms. In the sequential mechanism, the electron is ﬁrst
passed to the high-potential Rieske protein. This reaction results in the
remaining electron, now present as an unstable semiquinone (Q•), to
be passed to bL and then to bH. However, this historic mechanism lacks
the experimental evidence to support the existence of a semiquinone
intermediate at the Qo center. Trumpower and colleagues proposed a
reﬁnedmodel in which the oxidation of ubiquinol occurs by a concerted
mechanism inwhich electrons are simultaneously donated to the Rieske
protein and heme bL [53]. Cytochrome bL immediately reduces
cytochrome bH, which then reduces ubiquinone to the semiquinone at
the Qi site. The electron transfer from bL to bH also results in a protein
conformational change that facilitates movement of the Rieske Fe/S pro-
tein between cytochromes b and c1 [54].
3.3. Formation and maturation of bc1 redox sites
The individual maturation of cofactor-containing subunits re-
quires several deliberate steps, including cofactor delivery to the ap-
propriate cellular compartment, manipulation and/or preservation
of the apoprotein in a conformation amenable to cofactor insertion,
and ligation of the cofactor to the speciﬁc functional groups of the
subunit polypeptide. An additional complication is that all known c-
type holocytochromes are located in a different cellular compartment
than the site of either apo-polypeptide or heme synthesis [55]. It is
also unclear which side of the plasma membrane/inner membrane
hemylation takes place to form cytochromes b. Additionally, little is
known about the mechanism of b-type cytochrome maturation be-
cause assembly defects have severe cellular phenotypes [56].
3.3.1. Di-heme cytochrome b maturation
In prokaryotes, mutagenesis of the ligating histidine residues in cy-
tochrome b prevents cofactor insertion and results in a nonfunctional
enzyme that impairs bc1 assembly [56]. The non-covalent chemical na-
ture and lack of known speciﬁc assembly factors has led to the sugges-
tion that heme is spontaneously inserted into the apoprotein. This
assumption can be supported by in vitro experiments where heme is
able to bind synthetic peptides mimicking cytochrome b helices [57].
Thus, the model for bacterial bc1 complex assembly assumes that the
b hemes are inserted either very soon, after, or concurrent, with the
folding of the cytochrome b polypeptide into the membrane.
Maturation of cytochrome b is the nucleating factor in eukaryotic
bc1 complex biogenesis (Fig. 4). COB pre-mRNA is processed by the
matrix protein Cbp2 and the mitochondrial proteins Cbs1 and Cbs2,
which activate translation via interaction with the 5′ untranslated re-
gion of COB mRNA and the mitochondrial ribosome [58]. Cbp6 was
also identiﬁed as a translational activator of COB mRNA, but was
more recently found to form a complex with the matrix assembly
protein Cbp3 at the ribosomal exit tunnel, where the two proteins in-
teract with the newly synthesized Cob. The Cob–Cbp6–Cbp3 complex
recruits the additional IMS assembly factor Cbp4 after dissociation
with the ribosome [59]. An early assembly intermediate containing
Cob was identiﬁed by native gel electrophoresis in yeast lacking im-
portant bc1 subunits [60,61]. This intermediate also contained two
small bc1 subunits, Qcr7 and Qcr8. Although it remains unclear
whether the newly synthesized Cob associated with Cbp3, Cbp6 and
Cbp4 is a distinct complex from the Cob/Qcr7/Qcr8 assembly inter-
mediate, it is likely that the initial assembly intermediate contains
each of these assembly factors. This putative Cob-containing complexwith Cbp3, Cbp4, Cbp6, Qcr7 and Qcr8 may exist to stabilize Cob for
population of the two heme centers.
The mechanism of Cob hemylation is unknown. It remains unclear
whether the reaction occurs from the matrix or the IMS side of the IM.
Heme synthesis occurs on the matrix side of the IM by ferrochelatase.
The two heme moieties associated with Cob lie within a four-helix
bundle. If Cob hemylation occurs within the assembly intermediate
containing Qcr7, Qcr8, Cbp3, Cbp4 and Cbp6, the Qcr7 subunit and
the N-terminus of Qcr8 are packed against the matrix-facing loops
of Cob, blocking access to the four-helix bundle interior. In addition,
Cbp3 and Cbp6 are matrix-facing subunits that may also block access
to Cob. In contrast, the IMS side of the Cob intermediate would be de-
void of steric constraints by Qcr8. Cbp4 is projected to have a globular
domain facing the IMS, but Cbp4 is not conserved through eukary-
otes. Thus, hemylation may occur through the IMS surface of Cob.
No information exists on how heme is translocated across the IM,
yet that is an essential step, as heme is used in other cellular
compartments.
Hemylation of Cob is likely required for subsequent maturation of
the Cob/Qcr7/Qcr8 complex through the addition of subunits Cor1,
Cor2, Cyt1 and Qcr9 [61,62]. The late maturation step includes the ad-
dition of 2Fe–2S-containing Rip1 and Qcr10. Since Rip1 contains the
essential 2Fe–2S center that mediates electron transfer to the cyto-
chrome c1 subunit Cyt1, the late core intermediate is devoid of func-
tion. The addition of Rip1 and Qcr10 enables association with CcO,
forming the supercomplex in yeast [62,63].
3.3.2. Cytochrome c1 heme maturation
In prokaryotes, the Sec translocon delivers cytochrome c1 to the peri-
plasm where the covalent attachment of heme c to apo-cytochrome by
the system I machinery occurs early in bacterial bc1 complex biogenesis
[64]. Deletion, mutation, or removal of the transmembrane anchor of the
cytochrome c1 gene or mutation of the heme binding site of cytochrome
c1 protein prevents the addition of either cytochrome b or Rieske protein
subunits [65–67] to the complex. Furthermore, removal of the C-
terminal membrane anchor in R. sphaeroides causes retention of detect-
able amounts of the soluble holo-protein in the periplasm [67],
suggesting that heme c1 insertion occurs independently of Cyt1 mem-
brane insertion and that a functional holo-Cyt1 is required for assembly
and association of the remaining bc1 complex subunits.
Cyt1 is the only bc1 TM subunit oriented with its C-terminus di-
rected towards the matrix. Therefore, proper localization and
topogenesis requires a bipartite targeting signal sequence in Cyt1 to
direct its intra-mitochondrial sorting. Following inner membrane in-
sertion of the C-terminal tail, the heme c1 cofactor is inserted into
the new IMS-localized N-terminal domain of Cyt1 [68,69]. The ﬁnal
step in Cyt1 maturation is cleavage by the Imp2 signal peptidase to
remove the matrix and N-terminal TM portions of Cyt1, resulting in
mature holo-Cyt1 (Fig. 4). Positive heme staining on SDS-PAGE of
the intermediate form of Cyt1 is evidence that heme attachment oc-
curs prior to Imp2 processing. Furthermore, in the absence of Imp2,
the intermediate holo-cytochrome c1 persists [70].
In yeast, the covalent attachment of heme to apo-Cyt1 is medi-
ated by either of the two heme lyases in the IMS, CCHL and CC1HL
[70]. In mammals, the activities of both CCHL and CC1HL are pos-
sessed by the HCCS heme synthetase, which functions to assemble
both cytochrome c1 and the mobile IMS protein cytochrome c. Both
CCHL and HCCS can functionally substitute for CC1HL in yeast, al-
though the converse is not true [70]. Therefore, it remains possible
that CCHL and CC1HL are actually part of a larger complex that is
required for covalent bond formation in cytochrome c-type pro-
teins, and that the so-called lyases are not the catalytic component
of this complex.
The fungal CC1HL, designated Cyt2, is a small protein of 216 resi-
dues in S. cerevisiae. The N-terminal segments of CC1HL orthologs ex-
hibit considerable length variation, but contain dual CP motifs that
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Fig. 4. Hemylation of cytochrome b and cytochrome c1 polypeptides in eukaryotic bc1 complex. Translation of COB mRNA initiates bc1 complex biogenesis (1a). Cob forms a ternary
complex with the Cbp3/Cbp4/Cbp6 proteins independent of the mitochondrial ribosome (2a). Following transport of newly synthesized heme across the IM (3a), this is a possible
point at which heme is inserted into the apo-cytochrome b from the IMS side of the inner membrane. This insertion could occur prior to, in conjunction with, or post Qcr7 and Qcr8
additions (4a). Transport across the IM would not be required if the product heme from ferrochelatase is deposited into the IM (see Fig. 6a). Hemylation of Cob could also occur
directly from the matrix side. Apo-cytochrome c1 is synthesized in the cytosol and must be imported into the mitochondria through the inner and outer membrane translocases
(1b). A bipartite signaling sequence directs insertion into the IM (2b). Following transport of newly synthesized heme across the IM, the heme lyase, Cyt2, participates in the co-
valent attachment of heme c1 to apocytochrome c1 (3b). The ﬁnal step in holocytochrome c1 maturation is cleavage by Imp2 to remove the N-terminal membrane anchor, resulting
in an Nout–Cin topology (4b). PDB accession number: 3CX5 was used to generate the ﬁgure.
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CCHL protein catalyzes the thioether bond formation directly. An
alternative scenario is that Cyt2 is a chaperone that stabilizes
a conformation of Cyt1, allowing spontaneous thioether bond
formation.
The IMS protein Cyc2 has been identiﬁed both in a screen for mu-
tants deﬁcient in hemylated cytochrome c and also isolated as a mul-
ticopy suppressor in cells lacking CC1HL, suggesting a role in the
maturation of mitochondrial c-type cytochromes [72]. Cyc2 has a
non-covalently bound FAD cofactor with a proposed role in the
redox modulation of the heme lyase reaction. Cyc2 is essential for
hemylation of Cyt1 by CCHL, especially when the CxxCH (CAPCH)
heme-binding motif of Cyt1 is mutated to affect the redox chemistry
of the cysteinyl thiols [73]. However, Cyc2 is not required for the
hemylation of Cyt1 by its cognate CC1HL lyase. This observation sug-
gests that a different candidate reductase than Cyc2 may be necessary
for Cyt1 maturation.
Cyt1 along with Cor1, Cor2 and Qcr9 are added to the early core
assembly intermediate (Cob, Qcr7, Qcr8) to form the late core assem-
bly intermediate lacking only Rip1 and Qcr10. Hemylation of Cyt1
likely occurs prior to this assembly step, since it appears to precede
Imp2 proteolytic processing (Fig. 4). No information is available re-
garding whether hemylation of Cob and Cyt1 is coupled. Further re-
search is needed to deﬁne the steps and protein components
necessary for these hemylation reactions.4. Heme a of cytochrome c oxidase
4.1. Overview
Eukaryotic CcO is the terminal enzyme of the mitochondrial elec-
tron transport chain. A member of the heme-copper oxidase superfam-
ily, this enzyme catalyzes the reduction of molecular oxygen to water
concurrently with the oxidation of ferrocytochrome c. These redox re-
actions, like that in complex III, are coupled to the translocation of pro-
tons across the inner mitochondrial membrane contributing to theformation of the electrochemical proton gradient utilized to generate
ATP.
In contrast to its 3–4 subunit bacterial counterparts, eukaryotic
CcOs consist of 11 (yeast) to 13 (mammals) subunits; nevertheless,
the catalytic core of the enzyme formed by the three largest proteins,
Cox1, Cox2 and Cox3, shows a signiﬁcant degree of conservation
throughout evolution [74]. Three core subunits are encoded by mito-
chondrial DNA, while the additional subunits are products of the nu-
clear genome [75,76].
Structures of CcO enzymes have been elucidated from bovine
heart mitochondria as well as from bacterial counterparts Paracoccus
denitriﬁcans and Thermus thermophilus [9,77–80]. Cox1 is the largest
and most conserved of the core subunits. It is a highly hydrophobic
protein with 12 TM helices, and it contributes to both proton
pumping and oxygen reduction reactions. The second catalytic sub-
unit Cox2 has only 2 TM helices. Studies both in bacteria and eukary-
otes suggest that Cox3 is likely important for stability of the catalytic
core and modulates the proton pumping pathways in Cox1 [81]. The
additional nuclear-encoded subunits are important for both assembly
and function of the enzyme [75,76].
4.2. Organization and function of CcO redox sites
4.2.1. Structure of CcO redox sites
Redox sites of CcO are represented by the copper ions and the a-
type heme cofactors that together form very unique cofactor sites
found only in terminal oxidases (Fig. 5). The Cox2 subunit contains
the binuclear CuA center located within the IMS-exposed C-terminal
domain of Cox2. The other redox cofactors are present in Cox1. First,
the low-spin six-coordinate heme a is ligated by two axial histidyl li-
gands. The fully extended farnesyl group of this heme is inside an α-
helical bundle formed by helices 1, 11, and 12 of Cox1 [77,82]. The
second heme molecule exists within a heterobimetallic center con-
sisting of copper (designated CuB) and heme a. This heme, designated
a3, is ﬁve-coordinate high-spin, with a single axial ligand.
The CuB site resides 13 Å below the IM surface, and the heme a3 is
localized in a cavity with its farnesyl tail located at the interface of the
CuA
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Heme a3
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(Cox 1)
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Fig. 5. Arrangement of the hemes a and a3:CuB and CuA in CcO. The binuclear CuA center
is located in Cox2 subunit (transparent green) and is the entrance site for electrons
from reduced cytochrome c. Electrons are subsequently passed to the low-spin, bis-
His heme a and then to the heterobimetallic heme a3:CuB center in Cox1 (transparent
grey) where O2 reduction occurs. The axial ligands to the heme iron are highlighted
along with respective residue numbers and subunits (PDB ID: 2OCC numbering).
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Cox2 subunits has been reported to be an important factor for proper
coordination of heme a3 in mammalian CcO [83]. The cavity is partial-
ly solvent-accessible from the IMS side, and Cox2 docking in the
course of assembly appears to occlude the cavity [9,77]. Both hemes
have their farnesyl and vinyl groups extending toward the mitochon-
drial matrix side, while hydrophilic propionate moieties are facing
the IMS side.
4.2.2. Function of CcO redox sites
The CcO redox sites in combination with hydrogen bonds and the
peptide backbone form an intricate molecular wire that allows shut-
tling of the electrons through the enzyme [84]. The electrons from
the reduced cytochrome c enter CcO through the CuA center located
near the docking site of Cox2 and Cyc1. The CuA site is located 19 Å
away from the heme a prosthetic group. Electron transfer between
the CuA and heme a does not involve proton movement [85]. Elec-
trons in heme a are subsequently passed to the heterobimetallic
heme a3:CuB center where oxygen reduction occurs. For more de-
tailed reviews on CcO catalysis see [85,86].
4.3. Formation and maturation of CcO redox sites
As mentioned in Section 1, heme a is generated by the sequential
modiﬁcation of the protoheme, the product of ferrochelatase (Figs. 6
and 7a). In the ﬁrst step, a 17-hydroxyethylfarnesyl group is added to
the C2 vinyl side chain of heme b catalyzed by a farnesyltransferase-
type enzyme, generally referred to as heme o synthase (HOS). In many
bacterial oxidases, this intermediate heme o serves as a terminal pros-
thetic group. Unlike in bacteria, only trace amounts of heme o are found
in normalmitochondria, but detectable levels are observed in CcO assem-
bly mutants [87,88].
In the subsequent step, the C8 methyl group of heme o is converted
to a formyl group. Based on studies in bacteria, it has been postulated
that conversion occurs by sequential oxidation of the methyl group
through a short-lived C8-alcohol intermediate, sometimes referred to
as heme i or heme ox [89,90]. This reaction is performed by heme a
synthase (HAS). Oxidation of the C8 methyl group has been pro-
posed to proceed via two mono-oxygenase reactions [89]. However,
this mechanism has been challenged by O2 isotope-labeling studies
demonstrating no signiﬁcant incorporation of the label into either
heme a nor heme i [91]. The same study suggested that water
might be a donor of the oxygen atom in this reaction.
4.3.1. Heme o synthase
The heme o synthase (HOS) is designated Cox10 [92]. It is a large
membrane protein that in yeast assembles into a multimeric complex
of ~300 kDa believed to be a homo-oligomer [93]. The stability of the
Cox10 oligomer appears to depend on the presence of newly synthe-
sized Cox1 and its early assembly intermediates. This connection of
heme a biosynthesis and CcO biogenesis may serve regulatory pur-
poses to minimize excess and toxic levels of highly reactive heme a.
Cox10-catalyzed conversion of protoheme appears to be a rate-
limiting step in heme a formation, given its ~8-fold dearth over
Cox15 in yeast mitochondria [94]. It is therefore likely that regulation
of Cox10 abundance/activity is the way to modulate the heme a bio-
synthetic pathway.
An N196K gain-of-function mutation in Cox10 was identiﬁed as a
dominant suppressor in cells lacking the CcO assembly factor Coa2.
These studies established that Coa2 functions in concert with Cox10 in
the hemylation of Cox1 (see Section 4.4.2). While Cox10 exists only as
the monomer in coa2Δ cells and, apparently, is largely inactive, the
N196Kmutant Cox10 forms a stable oligomer, and the enzyme is active
as the cells respire normally [93]. Cox10 oligomerization appears to be a
key feature of HOS enzymatic activity.4.3.2. Heme a synthase
Heme a synthase was ﬁrst described in B. subtilis [95–97]. Further
studies identiﬁed eukaryotic orthologs commonly designated Cox15
[98,99]. Puriﬁed CtaA has been shown to contain sub-stoichiometric
amounts of both hemes b and a. This led to a conclusion that HAS is a
heme b-containing enzyme utilizing the cofactor at the active site,
akin to other oxygenases. Bound heme a was interpreted as an
unreleased reaction product [97]. A bioinformatic approach helped to
identify proteins acting in concert with Cox15. In Schizosaccharomyces
pombe, HAS exists as a part of a natural fusion protein, consisting of
Cox15 and a Yah1-like ferredoxin extension [100,101]. Further studies
conﬁrmed the involvement of Yah1 as well as ferredoxin reductase
Arh1 in heme a biosynthesis [88].
The catalytic domain of Cox15 is projected to exist on the IMS side of
the IM. Since the catalytic domain of Cox10 resides on thematrix side of
the IM, an unresolved question concerns how heme o is translocated to
the IMS side of the IM for Cox15-mediated oxidation. Electrons for this
step are likely passed through the heme b in Cox15 from ferredoxin in
the matrix.
Similar to HOS, heme a synthases are polytopic membrane-
embedded proteins with up to eight predicted TM segments [90,98].
Studies in yeast demonstrated that Cox15 forms a high molecular
weight complex [93,98], but its composition is unknown. Brown et
al. overexpressed B. subtilis CtaB and CtaA, as well as R. sphaeroides
Cox10 and Cox15 in E. coli and showed interaction of HOS and HAS
in both cases [91]. This observation led to the hypothesis that heme
o is channeled directly from HOS to HAS. Studies in yeast, however,
failed to demonstrate interaction of Cox10 and Cox15. Moreover,
the deletion of COX15 does not affect the stability of the Cox10 com-
plex and vice versa [93] (and our unpublished results). Unlike Cox10,
the Cox15 high-mass complex is not responsive to perturbations of
Cox1 synthesis or maturation.
Yeast lacking Cox15 contain no heme a, but show low levels of
heme o, suggesting that the two enzymes are not intricately linked
[87]. Likewise, ﬁbroblasts isolated from patients with fatal infantile
hypertrophic cardiomyopathy associated with mutations in Cox15
are characterized by reduced heme a levels, but heme o content is el-
evated [102]. It should be noted, however, that overexpression of
Farnesylation Formylation
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Fig. 6. Chemical modiﬁcations of heme b to heme a via heme o catalyzed by the enzymes Cox10 (Heme o synthase, HOS) and Cox15 (Heme a synthase, HAS). In mitochondria, heme
o is considered to be an intermediate and does not serve as a cofactor; where as in bacteria, heme o can functionally replace heme a in its terminal oxidase (e.g., cytbo3). Ferredoxin
Yah1 and adrenodoxin Arh1 supply electrons for Cox15-mediated heme o to heme a conversion.
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heme o levels. Based on this observation, Barros and Tzagoloff
suggested that there is positive regulation of HOS function by either
Cox15 or the product of the Cox15-catalyzed reaction.
4.4. Maturation of heme a-containing reactive sites within CcO
Hemylation of Cox1 is one of the key events in CcO biogenesis.
Heme a is required for stability and folding of the Cox1 subunit
[92,103,104]. This is consistent with structural data indicating that
heme a is not only a reactive site but also a “structural unit” linking
together distant helical bundles of Cox1. In some bacteria, such as R.
sphaeroides, CcO assembly proceeds normally even in the absence of
heme a [105]. Based on these observations, it has been assumedIM
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is incorporated into maturing Cox1 (d) to form the stable Cox1–Cox5a–Cox6 S2 complex (that hemylation of Cox1 occurs either co-translationally or upon its
incorporation into the lipid bilayer [106,107].
A more recent study indicated that Cox1 hemylation is a post-
translational event [108]. In yeast, CcO biogenesis initiates with Cox1
synthesis on mitochondrial ribosomes tethered to the IM by IM-
associated translational activators Pet309 and Mss51 (Fig. 7b). Mss51
has a second function in translational elongation of Cox1, which is per-
formed within a high-molecular-weight complex consisting of Mss51,
chaperone-like factors Cox14 and Coa3/Cox25, and mHsp70 chaperone
Ssc1, which represents, along with newly synthesized Cox1, an early
CcO assembly intermediate [75,76]. Cox1 maturation proceeds to
downstream assembly complexes containing assembly factors desig-
nated Coa1, Coa2 and Shy1 (SURF1 in humans) [108–111]. Neither the
Mss51- nor Coa1-containing Cox1 intermediates have the redox sitesCox6
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he matrix, where it is utilized for hemylation of complex II and complex III. A sub pop-
f heme a from Cox15 is unknown. As drawn, the heme exits on the matrix side of the IM
. Translation of COX1 mRNA commences CcO biogenesis (a). Newly synthesized Cox1
independent of the mitochondrial ribosome (b). Subsequently, Coa1 appears to mediate
rther rounds of Cox1 translation/assembly (c). With the help of Shy1 and Coa2, heme a
e). PDB accession number: 2OCC was used to generate the ﬁgure.
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involved in cofactor synthesis or incorporation) has no effect on
the stability of either complex. Likewise, these intermediates are
not affected in cox1 strains with mutated heme a axial ligands
[108].
The formation of both the heme a and the heme a3-CuB sites ap-
pears to occur within or adjacent to the Shy1/SURF1-containing
Cox1 assembly intermediate. Studies with ﬁbroblasts from patients
with mutations in Cox10 and Cox15 reveal the absence of the partial-
ly assembled Cox1 intermediate [102,112,113]. Similarly, the lack of
each protein in yeast affects the Shy1 associated Cox1 assembly inter-
mediate [108]. These observations are supported by the genetic inter-
actions in yeast between Cox10, Coa1, Shy1 and Coa2 [110,111]. CcO
assembly blocked at either Cox2 maturation or addition of the CuB
moiety results in accumulation of a transient Cox1 pro-oxidant inter-
mediate. The nature of such a pro-oxidant is not fully understood, but
it appears to correlate with the presence of a reactive ﬁve-coordinate
heme a3 [114]. The pro-oxidant heme a3:Cox1 intermediate is absent
in cells lacking Shy1 or Coa1 [111], another observation supporting
the postulate about the heme a maturation point.
There are a few lines of evidence that suggest the heme a site
may be formed earlier than the heme a3 center. First, CcO isolated
from R. sphaeroides or P. denitriﬁcans cells lacking SURF1 orthologs
is deﬁcient in heme a3 but not heme a [115,116]. Second, a stalled
Cox1 assembly intermediate containing a subset of nuclear-
encoded subunits is observed in the ﬁbroblasts from SURF1, but
not Cox10- or Cox15-deﬁcient patients [102,112,113]. It is plausible
that heme a insertion may be necessary for formation/stabilization
of the intermediate. Likewise, studies on the assembly of E. coli
bo3 oxidase, where heme b is analogous to the heme a of CcO, dem-
onstrated that formation of the heme b site is critical for further
maturation of the enzyme [117].
4.4.1. Shy1/Surf1 proteins
Heme a can spontaneously self-insert into maquettes, chemically
engineered four-helix bundles mimicking the ones of Cox1 [118].
However, questions exist regarding the speed and efﬁcacy of such in-
sertion, which become critical aspects in vivo, where unfolded hydro-
phobic proteins are quickly shielded or removed by quality control
systems to prevent aggregation and/or deleterious side effects [119].
It is therefore plausible that dedicated factors exist to facilitate
heme a insertion.
SURF1/Shy1 proteins have been implicated in heme a site forma-
tion. Although the exact role of the protein remains nebulous, P.
denitriﬁcans SURF1 isoforms were shown to bind heme a in a 1:1 stoi-
chiometry when co-expressed along with heme a biosynthetic en-
zymes in E. coli [120]. The same study identiﬁed a conserved
histidine residue important for heme binding and implicated SURF1
as a heme a insertase. In Thermacea bacteria, the ba3-type CcO biogen-
esis is independent of a SURF1 protein, but an unrelated CbaX factor is
required for heme a3 site formation [121]. The CbaX factor lacks any
histidine residues, and no heme binding studies were conducted.
The heme-insertase scenario may not hold true for eukaryotic
Shy1/SURF1; mutation of the conserved histidine residues in yeast
Shy1 has only minor or no effect on respiration [122]. Consistently,
yeast cells lacking Shy1, as well as SURF1-deﬁcient patient cell
lines retain substantial respiratory activity. Therefore, it remains
unclear whether Shy1/SURF1 simply acts as a chaperone stabilizing
the maturing Cox1 protein or whether it has a more direct role in
heme a3 insertion.
4.4.2. Coa2
Genetic studies in yeast identiﬁed another molecule, designated
Coa2, critical for Cox1 hemylation. Coa2 has been identiﬁed as a high-
copy suppressor of the respiratory defect in coa1Δ and shy1Δ deletion
strains and has been shown to transiently interact with Shy1 [111].Subsequent genetic studies found that Coa2 functions downstream of
Mss51 and Coa1 [93]. Cells lacking Coa2 exhibit a facile degradation of
Cox1 that appears to arise from impaired hemylation and subsequent
misfolding of the molecule [93,123]. The respiratory defect of coa2Δ
cells is suppressed by the dominant N196K gain-of-function mutation
in Cox10 [93]. The Cox10 high-mass complex is severely attenuated in
coa2Δ cells. The suppressive effect of the mutation is restricted to
Coa2-deﬁcient cells and appears to depend on restoration of the
Cox10 oligomeric state and the abundance of the oligomer. In addition,
attenuation of Oma1 protease substantially restores respiration in
coa2Δ cells [93,123]. The absence of the Oma1 protease appears to in-
crease the time for the inefﬁcient Cox1 hemylation process in coa2Δ
cells.
Similar to Shy1/SURF1, Coa2 does not appear to be a dedicated
heme chaperone; substitutions or removal of the residues that poten-
tially could constitute a heme-binding motif have no effect on respi-
ratory function (our unpublished results). Coa2 is important in
coupling Cox1 synthesis to Cox10 oligomerization and in addition ap-
pears to have a role in the formation of the low spin heme a site in
Cox1. It remains to be determined whether formation of the heme a
site occurs in a similar fashion in human mitochondria. No robust
mammalian homolog of Coa2 has been identiﬁed so far.5. Concluding remarks and perspective
Hemes are integral components of the respiratory complexes II,
III, and IV that perform multi-electron transport and catalysis. The
functional signiﬁcance of the heme in complex II remains unclear,
as does the relevance of its second quinone-binding site. An intrigu-
ing observation that the SDH subunit Sdh3 exists in a second com-
plex with Tim18 creates the possibility that heme has a role in the
TIM22 translocase for mitochondrial import of carrier proteins. Fu-
ture studies will need to resolve whether the hemes in SDH and
the Sdh3/Tim18 complex have only a structural role or participate
in an electron transfer reaction.
Important biological questions persist regarding the maturation
of heme centers in complex III and complex IV. Hemylation of the
subunit Cob of complex III, for example, is likely required for subse-
quent nucleation biogenesis of additional subunits. It will be impor-
tant to resolve at which stage of Cob maturation the heme
is inserted, and whether additional proteins function in the
hemylation reaction. Covalent association of heme with cytochrome
c and c1 occurs in the IMS, yet information is lacking on how heme is
translocated from the site of its formation on the matrix-facing sur-
face of the IM back to the IMS. The translocation step is likely
coupled to heme presentation to the proteins involved in covalent
heme addition. Complex IV biogenesis is closely linked to heme
site maturation. Signiﬁcant questions persist on the mechanism of
heme a insertion into Cox1 from the IMS side of the IM as well as
the translocation of heme o from the matrix side of the IM to
Cox15. The heme b in Cox15 is likely a key cofactor for the electron
transfer from ferredoxin in the matrix to the Cox15 reaction center.
A ﬁnal key question remains on whether bioavailable heme b pools
exist within the mitochondria or IMS for hemylation reactions. Al-
though much information is known for heme reaction mechanisms,
the biological movement of heme for use in hemylation reactions re-
mains uncharacterized.Acknowledgments
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